Showing results (971-980 of 9,404) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|November 1, 1996
A possible interaction of potential clinical interest between digoxin and acarboseJ S Serrano, C M Jiménez, M I Serrano, et al.Clinical Pharmacology and Therapeutics|September 1, 1977
Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism. Antipyrine, pentobarbital, and ethanolN L Benowitz, R T JonesClinical Pharmacology and Therapeutics|September 1, 1977
Comparative pharmacodynamics of betamethyl digoxin and digoxin in manG P Das, R N Talmers, A M WeisslerClinical Pharmacology and Therapeutics|September 1, 1996
The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairmentN N Vachharajani, W C Shyu, W R Garnett, et al.Clinical Pharmacology and Therapeutics|September 1, 1996
Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteersJ Lötsch, A Stockmann, G Kobal, et al.Clinical Pharmacology and Therapeutics|September 1, 1996
The effect of ingestion time interval on the interaction between itraconazole and triazolamP J Neuvonen, A Varhe, K T OlkkolaClinical Pharmacology and Therapeutics|August 1, 1977
Kinetics of intravenous theophyllineF A Chrzanowski, P J Niebergall, R L Mayock, et al.Clinical Pharmacology and Therapeutics|August 1, 1977
Kinetics of primidone metabolism and excretion in childrenR E Kauffman, R Habersang, L LanskyClinical Pharmacology and Therapeutics|August 1, 1977
Adjustment of lithium dose during lithium-chlorothiazide therapyJ M Himmelhoch, R I Poust, A G Mallinger, et al.Clinical Pharmacology and Therapeutics|April 4, 2006
Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitorsXiao-Min Wang, Tian-Xia Wu, Yun-Sil Lee, et al.Pageof 941